Tomayko Group helps companies save money on health care
The Tomayko Group LLC, an integrated health care services company in the South Side, makes money because companies are forever trying to save money on health care.
Why? In the past five years, for instance, companies' employee health insurance costs have jumped 30 percent, according to the Kaiser Family Foundation.
The group's main growth engine is its Integrated Corporate Health business, which provides corporate wellness programs and health screenings for companies. Healthier workers help the companies reduce their medical insurance costs.
“Health care costs at companies are rising at such high rates that they want to get those costs under control,” said John “Jack” Tomayko, president and principal owner.
Tomayko estimates the group's revenue will increase about 30 percent this year, to $26 million from the $20 million it posted last year.
The Tomayko Group includes five other businesses, which provide diagnostic imaging equipment and services, radioisotopes for imaging, clinical staffing, and licensing and accreditation support.
“We are very vertically integrated,” said Tomayko, who has a Ph.D. in health management from the University of Pittsburgh.
Integrated Corporate Health, or ICH, gets the bulk of its business via contracts with health insurers, such as Highmark and Coventry HealthAmerica, plus insurance brokers, which send ICH to their company clients to screen employees and conduct wellness programs.
“We'll do between 80,000 and 100,000 biometric screenings this year,” Tomayko said. “That's twice as many as we did last year, which is twice as many as we did the year before.”
For instance, ICH provides biometric screening — blood pressure, obesity, cholesterol and the like — to approximately 16,000 Penn State University employees.
Coventry HealthAmerica, which began using ICH in early 2012, values ICH's flexibility to meet the needs of the insurer's clients, wellness coordinator Angela Vitelli said.
“We've got a lot of manufacturer clients who have shifts that start at 5 or 6 a.m., which means (ICH) has to arrive for screening people at 4 a.m. or arrive at multiple buildings at one location,” Vitelli said. “And they rarely say it's not something they can do.”
The Tomayko Group's main revenue driver is its nuclear pharmacy business, which provides the radioisotopes used by hospitals, health clinics and private medical offices for diagnostic imaging. When injected into the patient or swallowed, radioisotopes enable imaging equipment to detect cancer, heart ailments and kidney stones. A related business leases and maintains the imaging equipment, as well as supplies the technicians.
The group landed a subcontract in February to supply radioisotopes to 19 UPMC test sites that should raise the nuclear pharmacy business' revenue about 40 percent this year, Tomayko said.
The group's diverse businesses help it cope with the challenges of hospital consolidation and general decline in health care reimbursements, Tomayko said.
In addition, the early 2012 acquisition of Cardiologic LLC, a nuclear cardiology management firm in Bala Cynwyd, opened the group to the Philadelphia metro market. It represented “a very good strategic move,” said Tomayko, because the market is much bigger than Pittsburgh and hospital consolidation does not affect his company as much.
Next, the group plans to diversify into “infection control services” to prevent disease and cut hospital readmissions, he said. The idea is to form a business around disinfecting hospital rooms, nursing homes and even locker rooms.
“Anything that can save money and prevent infections,” Tomayko said.
Thomas Olson is a Trib Total Media staff writer. He can be reached at 412-320-7854 or email@example.com.